RNAAtrium Therapeutics Inc.
$11.80
$0.50
(4.07%)
Closed $11.80
$0.19
(1.61%)
After Hours
Mkt Cap$210.4M
Vol209,488.00
Fundamentals
Mkt Cap
$210.4M
Volume
-
52W High
$16.77
52W Low
$11.77
PE Ratio
-
Avg. Volume
206,791.38
EPS (Annual)
-$2.89
Rev/Employee
-
Earnings
-
Atrium Therapeutics Reports First Quarter 2026 Financial Results
Atrium Therapeutics Reports First Quarter 2026 Financial Results Atrium Therapeutics Reports First Quarter 2026 Financial Results PR Newswire SAN DIEGO, May 14, 2026 SAN DIEGO, May 14, 2026...
PR Newswire
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers...
PR Newswire
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, April...
PR Newswire
Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies
Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies Atrium Therapeutics Launches with Approximately $270 Million to Advance...
PR Newswire
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference Avidity Biosciences Announces Multiple Upcoming...
PR Newswire
Promising Medical Stocks To Follow Today - February 26th
Eli Lilly and Company, UnitedHealth Group, Arcellx, Avidity Biosciences, and Novo Nordisk A/S are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks...
MarketBeat
Promising Pharmaceutical Stocks To Follow Now - February 26th
Eli Lilly and Company, Avidity Biosciences, Novo Nordisk A/S, AbbVie, Gilead Sciences, Abbott Laboratories, and Pfizer are the seven Pharmaceutical stocks to watch today, according to MarketBeat's...
MarketBeat
Avidity Biosciences (NASDAQ:RNA) Issues Quarterly Earnings Results
Avidity Biosciences (NASDAQ:RNA - Get Free Report) released its earnings results on Monday. The biotechnology company reported ($1.59) earnings per share for the quarter, missing analysts' consensus...
MarketBeat
Avidity Biosciences, Inc. $RNA Shares Bought by Vanguard Group Inc.
Vanguard Group Inc. grew its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA - Free Report) by 42.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC...
MarketBeat
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders PR...
PR Newswire
<
1
2
...
>
Advertisement|Remove ads.
Latest RNA News
ViewAtrium Therapeutics Reports First Quarter 2026 Financial Results
PR Newswire
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
PR Newswire
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Advertisement|Remove ads.